The Current Ratio as of November 2024 (TTM) for Myriad Genetics, Inc. (MYGN) is 1.27

According to Myriad Genetics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.27. This represents a change of -21.07% compared to the average of 1.61 of the last 4 quarters.

Myriad Genetics, Inc. (MYGN) Historical Current Ratio (quarterly & annually)

How has MYGN Current Ratio performed in the past?

The mean historical Current Ratio of Myriad Genetics, Inc. over the last ten years is 3.11. The current 1.27 Current Ratio has changed 3.98% with respect to the historical average. Over the past ten years (40 quarters), MYGN's Current Ratio was at its highest in in the December 2013 quarter at 8.62. The Current Ratio was at its lowest in in the September 2016 quarter at 1.17.

Myriad Genetics, Inc. (MYGN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Myriad Genetics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Myriad Genetics, Inc. (MYGN) Average Current Ratio

How has MYGN Current Ratio performed in the past?

The current Current Ratio of Myriad Genetics, Inc. (MYGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Myriad Genetics, Inc. (MYGN) Current Ratio vs. Peers

How is MYGN’s Current Ratio compared to its peers?

Myriad Genetics, Inc.’s Current Ratio is less than Guardant Health, Inc. (6.22), less than CareDx, Inc (4.10), less than Invitae Corporation (2.39), less than Castle Biosciences, Inc. (7.78), less than Sotera Health Company (2.88), greater than Syneos Health, Inc. (1.13), less than Neogen Corporation (4.41), less than RadNet, Inc. (2.16), less than Natera, Inc. (4.39), greater than Medpace Holdings, Inc. (0.99), less than Personalis, Inc. (4.68), less than Qiagen N.V. (2.17), less than Olink Holding AB (publ) (5.60), less than Aclaris Therapeutics, Inc. (7.03), less than Exact Sciences Corporation (2.12), less than Illumina, Inc. (2.43), less than Twist Bioscience Corporation (4.88),

Build a custom stock screener for Myriad Genetics, Inc. (MYGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Myriad Genetics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Myriad Genetics, Inc. (MYGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Myriad Genetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.